Abiopharma

News list

📋 HOLTUG LARS (Director) plans to sell 236 shares of Ascendis Pharma A/S (at $264.13 each, total $62K) Filed: Sep 02, 2026 | ID: 000330

Full text

News bot Sept. 2, 2026, 4:53 p.m.
📋 Form 144 Filing: HOLTUG LARS

Company: Ascendis Pharma A/S

Filing Date: 2026-09-02

Relationship: Director
Planned Sale Details:
- Security: ORDINARY SHARES
- Shares to be Sold: 236
- Price per Share: $264.13
- Total Value: $62,334.59
- Planned Sale Date: 2026-09-02
- Broker: CITIGROUP GLOBAL MARKETS
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-36815
- Issuer Contact Phone: 45 70 22 22 44
- Issuer Address: TUBORG BOULEVARD 12, HELLERUP, G7, DK2900
- Broker Address: 390 GREENWICH ST, NEW YORK, NY, 10013
- Shares Outstanding: 61977408.0
- Number of Securities to be Sold: 1
- Remarks: SECTION 3 D IS BASED ON INDICATIVE MARKET PRICE 264.1296. UNDER SECURITIES TO BE SOLD DATE ACQUIRED ARE VARIOUS. SALE OF SHARES TO COVER INCOME TAX
- Signature: CONFORMED SIGNATURE ON FILE